what do glp-1 agonists do Can one drug it all? Reviewing the expanding clinical universe of Evolution of GLP‐1 Receptor Agonists
Description
Archived from the original on 23 March 2019
J Diabetes Res 2019(9426014)
When switching between GLP1RAs, transient GI AEs are expected and can be reduced by slow uptitration, including use of intermediary doses, and advising patients to reduce portion sizes and fat intake
doi: 10.1007/s11033-014-3302-7
That last part is crucial
